Close Server: KOPWWW05 | Not logged in

Welcome to Health Care POV | sign in | join
ADVANCE Perspective: Respiratory Views

LUNGevity Launches #ThisIsHope Campaign

Published April 29, 2016 9:07 AM by ADVANCE for Respiratory Care & Sleep Medicine

By Tamer Abouras

Cancer occupies a singular, ugly space in the hearts and minds of many. Those few unaffected — at least tangentially — by the disease dread the mere mention of it ever coming to their door. Those who have been affected, either personally or through the battle of a loved one, know all too well the grim prospects and unimaginably difficult challenges that come with a diagnosis.

In spite of this doom and gloom, however, many organizations — both public and private — have worked tirelessly to research potential cures and treatments for cancer in virtually all of its forms.

And in recent years, many have made significant strides.

With the month of May right around the corner, LUNGevity, the nation's leading lung cancer-focused nonprofit, is celebrating the month it deemed Lung Cancer Hope Month four years ago with a brand
new campaign: #ThisIsHope. The social media campaign is aimed at creating a variety of opportunities for advocate, participate in events, mentor one-on-one and share hope.

SEE ALSO: Asthma Inhalers Get Smart

According to a press release from LUNGevity, #ThisIsHope “ … will spotlight the many faces of hope — survivors living longer, better lives; doctors making strides in research; family and friends enjoying more time with loved ones with lung cancer; and social media users who want to join the celebration of hope. Participants are encouraged to share photos of themselves and their loved ones on Facebook, Twitter and Instagram using the social media handle #ThisIsHope.”

For those interested in spreading awareness about lung cancer, LUNGevity has on its website ( a downloadable advocacy toolkit, a list of volunteer events taking place across the country that all are welcome to participate in and even the option to create an event of your own to help raise funds for continued research.

Another neat aspect of this month is the ability of lung cancer survivors and caregivers to sign up to mentor those who could benefit from hearing about their past experiences. According to the press release, in LUNGevity's LifeLine program “ … mentors are matched with newer patients and caregivers, and through the Clinical Trial Ambassador program, clinical trial veterans are paired with first-time lung cancer clinical trial participants to help guide them through the process.”

ADVANCE Opinion Poll: Would you choose to be an RT again?

The LUNGevity Foundation also provided these helpful statistics — and sobering reminders — of how far there is still to go in the fight against lung cancer:
  • 1 in 15 Americans will be diagnosed with lung cancer in their lifetime
  • More than 221,000 people in the U.S. will be diagnosed with lung cancer this year
  • About 60%-65% of all new lung cancer diagnoses are among people who have never smoked or are former smokers
  • Lung cancer takes more lives than the next three leading cancers (colorectal, breast and prostate) combined
  • Only 17% of all people diagnosed with lung cancer will survive 5 years or more, but if it's caught before it spreads, the chance for 5-year survival improves dramatically

Lung cancer doesn’t need to be a death sentence. There’s research to be done, tests to be conducted and funds to be raised, but there are many, many people working cooperatively in the effort to bring it to an end once and for all. And there is hope, because of initiatives like #ThisIsHope.

You Might Also Like...

Lung Cancer Resource Center

Expert lung cancer articles break down the symptoms, latest research and treatment options.

Lung Cancer Discovery

Protein inhibition therapy holds promise for treatment of NSCLC.

Demystifying Mesothelioma

Differences in diagnosis and treatment from lung cancer.


Novel ALK-inhibitor is used for the treatment on non-small cell lung cancer.



leave a comment

To prevent comment spam, please type the code you see below into the code field before submitting your comment. If you cannot read the numbers in the image, reload the page to generate a new one.

Enter the security code below:


About this Blog

Keep Me Updated